Stockreport

Late-stage study underway for Aldeyra's allergic conjunctivitis med reproxalap; shares up 2% [Seeking Alpha]

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations
PDF Late-stage study underway for Aldeyra's allergic conjunctivitis med reproxalap; shares up 2%The first patient has beenenrolled in a Phase 3 clinical trial evaluating Ald [Read more]